(−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo
- Supplementary File 1:
PDF-Document (PDF, 553 KiB)
Siddique, A.B.; Ebrahim, H.Y.; Akl, M.R.; Ayoub, N.M.; Goda, A.A.; Mohyeldin, M.M.; Nagumalli, S.K.; Hananeh, W.M.; Liu, Y.-Y.; Meyer, S.A.; El Sayed, K.A. (−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo. Nutrients 2019, 11, 412. https://doi.org/10.3390/nu11020412
Siddique AB, Ebrahim HY, Akl MR, Ayoub NM, Goda AA, Mohyeldin MM, Nagumalli SK, Hananeh WM, Liu Y-Y, Meyer SA, El Sayed KA. (−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo. Nutrients. 2019; 11(2):412. https://doi.org/10.3390/nu11020412
Chicago/Turabian StyleSiddique, Abu B.; Ebrahim, Hassan Y.; Akl, Mohamed R.; Ayoub, Nehad M.; Goda, Amira A.; Mohyeldin, Mohamed M.; Nagumalli, Suresh K.; Hananeh, Wael M.; Liu, Yong-Yu; Meyer, Sharon A.; El Sayed, Khalid A. 2019. "(−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo" Nutrients 11, no. 2: 412. https://doi.org/10.3390/nu11020412